Cargando…
HIV-1 drug resistance testing from dried blood spots collected in rural Tanzania using the ViroSeq HIV-1 Genotyping System
OBJECTIVES: To assess whether the commercial ViroSeq HIV-1 Genotyping System (Abbott Molecular, Des Plains, IL, USA) can be used in conjunction with dried blood spots (DBS) for clinical monitoring of drug resistance in patients who fail antiretroviral treatment (ART) in rural Tanzania. PATIENTS AND...
Autores principales: | Johannessen, Asgeir, Garrido, Carolina, Zahonero, Natalia, Naman, Ezra, de Mendoza, Carmen |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3019084/ https://www.ncbi.nlm.nih.gov/pubmed/21115444 http://dx.doi.org/10.1093/jac/dkq433 |
Ejemplares similares
-
LETTER TO THE EDITOR Performance of the ViroSeq® HIV-1 Genotyping System v2.0 in Central Africa
por: Mouafo, Linda Chapdeleine Mekue, et al.
Publicado: (2015) -
Comparison of an in-house ‘home-brew’ and commercial ViroSeq integrase genotyping assays on HIV-1 subtype C samples
por: Seatla, Kaelo K., et al.
Publicado: (2019) -
HIV-1 drug resistance genotyping from dried blood spots stored for 1 year at 4°C
por: Youngpairoj, Ae S., et al.
Publicado: (2008) -
Antiretroviral treatment reverses HIV-associated anemia in rural Tanzania
por: Johannessen, Asgeir, et al.
Publicado: (2011) -
Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania
por: Johannessen, Asgeir, et al.
Publicado: (2008)